"Vitiligo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Descriptor ID |
D014820
|
| MeSH Number(s) |
C17.800.621.440.895
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitiligo".
Below are MeSH descriptors whose meaning is more specific than "Vitiligo".
This graph shows the total number of publications written about "Vitiligo" by people in this website by year, and whether "Vitiligo" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 1 | 3 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitiligo" by people in Profiles.
-
Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. J Invest Dermatol. 2018 09; 138(9):2072-2075.
-
Concomitant mycosis fungoides and vitiligo: how mycosis fungoides may contribute to melanocyte destruction. Dermatology. 2015; 230(2):143-9.
-
Clinicopathological correlation of acquired hypopigmentary disorders. Indian J Dermatol Venereol Leprol. 2013 May-Jun; 79(3):376-82.
-
HIV photodermatitis presenting with widespread vitiligo-like depigmentation. Dermatol Online J. 2012 Jan 15; 18(1):6.
-
Focus on FOCIS: interleukin 2 treatment associated autoimmunity. Clin Immunol. 2008 May; 127(2):123-9.
-
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A. 2003 Jul 08; 100(14):8372-7.
-
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med. 2000 Dec 04; 192(11):1637-44.
-
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo. Cancer Res. 2000 Jan 15; 60(2):253-8.
-
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other". Crit Rev Immunol. 2000; 20(6):433-50.
-
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):2982-7.